Stimulation of phosphoinositides by agents that stimulate proton secretion in toad urinary bladder.
The urinary bladder of Bufo marinus excretes H+ and this excretion is increased by metabolic acidosis (MA), insulin (IN), prostaglandin E2 (PGE2), increases CO2, and aldosterone. The purpose of this experiment was to determine whether MA, IN, PGE2, CO2, and aldosterone stimulate inositol phosphate's (IP) formation in isolated cells of toad urinary bladder. Cells were prepared by treating bladder sacs with collagenase. Cells were obtained from 10 toads in MA and 10 normal toads, suspended in 2 ml of Ringer's solution containing LiCl (10 mM), myo-inositol (5 mM), and [3H]myo-inositol (10 microCi), and then incubated for 2 hr at 25 degrees C. Cells were homogenized and the IP fractions quantitated by column chromatography and liquid scintillation counting. The results were expressed as dpm (mu MPO4)-1 (hr)-1. The IP in MA cells was 44,202 +/- 4,646 and in normal toad cells it was 31,637 +/- 3,613 (P < 0.05). In a separate experiment, cells from 10 paired hemibladders were isolated from normal toads. The cells were treated exactly as above except there were no LiCl in the bath. LiCl was added to all baths after 2 hr and the experimental cells were challenged with IN, PGE2, increases CO2, and aldosterone for 20 min. The IP were quantitated as above. IN treatment stimulated inositol bisphosphate and inositol triphosphate (P < 0.01). PGE2 and increases CO2 also stimulated inositol triphosphate (P < 0.05). Aldosterone did not alter formation of any of the IP fractions. We conclude that MA, IN, PGE2, and increases CO2 stimulate IP formation in cells of toad urinary bladder and inositol triphosphate may be an important second messenger in mediating the response of MA, IN, PGE2, and increases CO2.
Frazier
L W
LW
Department of Biomedical Sciences, Baylor College of Dentistry, Dallas, Texas 75246.
D000138:Acidosis / Q000378:metabolism; D000450:Aldosterone / Q000494:pharmacology; D000818:Animals; D002024:Bufo marinus; D002245:Carbon Dioxide / Q000494:pharmacology; D015232:Dinoprostone / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007295:Inositol Phosphates / Q000378:metabolism*; D007328:Insulin / Q000494:pharmacology; D010042:Ouabain / Q000494:pharmacology; D010716:Phosphatidylinositols / Q000378:metabolism*; D006180:Proton-Translocating ATPases / Q000378:metabolism; D011522:Protons; D001743:Urinary Bladder / Q000378:metabolism
D007295:Inositol Phosphates; D007328:Insulin; D010716:Phosphatidylinositols; D011522:Protons; D002245:Carbon Dioxide; D000450:Aldosterone; D010042:Ouabain; D006180:Proton-Translocating ATPases; D015232:Dinoprostone